The Neuralert Stroke Monitor Pilot Trial
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Neuralert Technologies LLC
- Study ID
- NCT06368193
- Status
- Recruiting
Conditions
- Stroke
- Surgery
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Neuralert Monitor — DEVICEDevice to identify upper extremity asymmetry in patients who are high risk for stroke.
Study Details
This trial aims to demonstrate that the Neuralert Monitoring System will detect strokes before they would be identified by current standard of care. Each patient will be monitored for up to five days, depending on device connectivity or battery duration. Each monitoring session will consist of wearing a Neuralert device on each arm. For this pilot trial, we are interested in learning about Wi-Fi connectivity, successful data transmission, integration into clinical workflow, usability and tolerability.
Key Dates
- Start date
- Dec 12, 2024
- Status verified
- Jan 2026
- Primary completion
- May 1, 2026
- Completion
- May 1, 2027
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Cardiac Surgery Patients OR Neurology Patients
Primary Outcome Measure
Time to Nursing Response [ Time Frame: Up to 5 days post patient surgery ]
Central Contacts
- Brett Cucchiara, MD(215) 662-6738
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Brett Cucchiara, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Philadelphia, PA
By condition
By specialty
By research site
Related Studies
- The Pediatric Anesthesia Quality Improvement ProjectRecruiting · The Society for Pediatric Anesthesia · Phoenix, Arizona
- Improving Measurement and Treatment of Post-stroke NeglectRecruiting · VA Office of Research and Development · Pittsburgh, Pennsylvania
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas